Raymond James Financial »

Crinetics Pharmaceuticals In shares owned by Raymond James Financial

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 33k 46.55
2025-06-30 $45k 1.6k 28.76

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)

View all positions for Raymond James Financial

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Baker Bros. Advisors
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In